Bioxytran Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19 (NCT05096052) | Bioxytran Inc. | 2022-04-01 |
Track Bioxytran Inc. automatically
Every clearance here is in the API, with alerts when new ones post.